The post contains more than 140 new customer stories, which appear in italics at the beginning of each section of customer lists. The post will be updated regularly with new stories. One of the ...
UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment based on psilocybin – an active ingredient that can be found in magic mushrooms.